Position in ELAN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,764,838
+$1,353,270 QoQ
Shares Held
449,847
+8.2% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.13269845080661.ToString("F0")%
Shared 0.ToString("F0")%
None 1.8673015491933924.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $156,211,352 across 33 Drug Manufacturers - Specialty & Generic names. ELAN ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
225,051 | $29,648,218 | |
| 2 | ZTS |
Zoetis Inc.
|
202,071 | $23,886,812 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,281 | $20,327,947 | |
| 4 | ELAN |
Elanco Animal Health Inc
This page
|
449,847 | $10,764,838 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
286,100 | $8,720,328 | |
| 6 | VTRS |
Viatris Inc
|
597,766 | $8,075,817 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
511,957 | $6,363,625 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,156 | $6,239,538 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,764,838 | 449,847 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,411,568 | 415,889 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,932,368 | 691,776 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $56,503,975 | 3,956,861 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $60,167,688 | 5,730,256 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $51,164,713 | 4,224,997 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $44,216,973 | 3,010,005 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $43,769,653 | 3,033,240 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $46,673,783 | 2,866,940 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $96,070,581 | 6,447,690 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $31,659,573 | 2,816,688 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,586,555 | 2,344,588 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,932,424 | 418,343 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,677,083 | 300,907 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,432,610 | 115,440 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $1,166,492 | 59,424 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,409,876 | 54,039 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $941,506 | 33,175 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,079,539 | 33,852 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,173,214 | 379,741 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $855,492 | 29,049 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $875,597 | 28,549 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $260,028 | 9,310 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $30,737 | 1,433 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $13,389 | 598 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||